Literature DB >> 17681354

Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.

Tanya L Daigle1, Christopher S Kearn, Ken Mackie.   

Abstract

Molecular mechanisms regulating the development of physiological and behavioral tolerance to cannabinoids are not well understood. Two cellular correlates implicated in the development and maintenance of tolerance are CB(1) cannabinoid receptor internalization and uncoupling of receptor signal transduction. Both processes have been proposed as mediators of tolerance because of observations that chronic Delta(9)-tetrahydrocannabinol (THC) treatment causes both region-specific decreases in CB(1) receptors and G-protein coupling in the brain. To determine the balance of these two processes in regulating CB(1) receptor signaling during sustained receptor stimulation, we evaluated the parameters affecting ERK1/2 MAP kinase activity in HEK293 cells stably expressing CB(1) receptors. CB(1) receptor stimulation by the potent CB(1) receptor agonist, CP 55,940 transiently activated ERK1/2. To determine if CB(1) receptor desensitization or internalization was responsible for the transient nature of ERK1/2 activation, we evaluated ERK1/2 phosphorylation in HEK293 cells expressing a desensitization-deficient CB(1) receptor (S426A/S430A CB(1)). Here, the duration of S426A/S430A CB(1) receptor-mediated activation of ERK1/2 was markedly prolonged relative to wild-type receptors, and was dynamically reversed by SR141716A. Interestingly, the S426A/S430A CB(1) receptor was still able to recruit betaarrestin-2, a key mediator of receptor desensitization, to the cell surface following agonist activation. In contrast to a central role for desensitization, pharmacological and genetic approaches suggested CB(1) receptor internalization is dispensable in the transient activation of ERK1/2. This study indicates that the duration of ERK1/2 activation by CB(1) receptors is regulated by receptor desensitization and underscores the importance of G-protein uncoupling in the regulation of CB(1) receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17681354      PMCID: PMC2277473          DOI: 10.1016/j.neuropharm.2007.06.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  40 in total

1.  A monomeric red fluorescent protein.

Authors:  Robert E Campbell; Oded Tour; Amy E Palmer; Paul A Steinbach; Geoffrey S Baird; David A Zacharias; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

2.  Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures.

Authors:  Seksiri Arttamangkul; Maria Torrecilla; Kazuto Kobayashi; Hideyuki Okano; John T Williams
Journal:  J Neurosci       Date:  2006-04-12       Impact factor: 6.167

Review 3.  International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Authors:  A C Howlett; F Barth; T I Bonner; G Cabral; P Casellas; W A Devane; C C Felder; M Herkenham; K Mackie; B R Martin; R Mechoulam; R G Pertwee
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

4.  Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture.

Authors:  Maria Kouznetsova; Brooke Kelley; Maoxing Shen; Stanley A Thayer
Journal:  Mol Pharmacol       Date:  2002-03       Impact factor: 4.436

5.  Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.

Authors:  Alexander F Hoffman; Murat Oz; Tara Caulder; Carl R Lupica
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

6.  Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation.

Authors:  M Carmen Jiménez-Sainz; Beate Fast; Federico Mayor; Anna M Aragay
Journal:  Mol Pharmacol       Date:  2003-09       Impact factor: 4.436

7.  Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail.

Authors:  Helena Andersson; Aaron M D'Antona; Debra A Kendall; Gunnar Von Heijne; Chen-Ni Chin
Journal:  Mol Pharmacol       Date:  2003-09       Impact factor: 4.436

8.  Cloning and molecular characterization of the rat CB2 cannabinoid receptor.

Authors:  Sean M Brown; James Wager-Miller; Ken Mackie
Journal:  Biochim Biophys Acta       Date:  2002-07-19

9.  The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.

Authors:  Christopher S Breivogel; Susan M Scates; Irina O Beletskaya; Olivia B Lowery; Mario D Aceto; Billy R Martin
Journal:  Eur J Pharmacol       Date:  2003-01-17       Impact factor: 4.432

10.  Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.

Authors:  Pascal Derkinderen; Emmanuel Valjent; Madeleine Toutant; Jean-Christophe Corvol; Hervé Enslen; Catherine Ledent; James Trzaskos; Jocelyne Caboche; Jean-Antoine Girault
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

View more
  64 in total

1.  Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells.

Authors:  George D Dalton; Allyn C Howlett
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.

Authors:  Garron T Dodd; Giacomo Mancini; Beat Lutz; Simon M Luckman
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

3.  Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b).

Authors:  Pratishtha Singh; Anjali Ganjiwale; Allyn C Howlett; Sudha M Cowsik
Journal:  J Chem Inf Model       Date:  2019-12-10       Impact factor: 4.956

4.  Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.

Authors:  Brady K Atwood; James Wager-Miller; Christopher Haskins; Alex Straiker; Ken Mackie
Journal:  Mol Pharmacol       Date:  2011-11-07       Impact factor: 4.436

5.  CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Hippocampus       Date:  2014-02       Impact factor: 3.899

6.  Tolerance to WIN55,212-2 is delayed in desensitization-resistant S426A/S430A mice.

Authors:  Caitlin M Nealon; Angela N Henderson-Redmond; David E Hale; Daniel J Morgan
Journal:  Neuropharmacology       Date:  2019-01-08       Impact factor: 5.250

7.  CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.

Authors:  Liting Deng; Benjamin L Cornett; Ken Mackie; Andrea G Hohmann
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

8.  JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist.

Authors:  Brady K Atwood; John Huffman; Alex Straiker; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-01-22       Impact factor: 8.739

9.  Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.

Authors:  Christine Börner; Michal Smida; Volker Höllt; Burkhart Schraven; Jürgen Kraus
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

10.  Mastering tricyclic ring systems for desirable functional cannabinoid activity.

Authors:  Ravil R Petrov; Lindsay Knight; Shao-Rui Chen; Jim Wager-Miller; Steven W McDaniel; Fanny Diaz; Francis Barth; Hui-Lin Pan; Ken Mackie; Claudio N Cavasotto; Philippe Diaz
Journal:  Eur J Med Chem       Date:  2013-09-29       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.